» Articles » PMID: 17186731

[Experimental Study on Osteoking in Promoting Gene Expression of Core Binding Factor Alpha 1 in Necrotic Femoral Head of Rabbits]

Overview
Date 2006 Dec 26
PMID 17186731
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the effects of Osteoking in promoting gene expression of core binding factor alpha 1 (cbfalpha 1) in necrotic femoral head of rabbits.

Methods: Rabbit model of femoral head necrosis (FHN) was induced by intravenous injection of lipopolysaccharide (LPS) 10 microg/kg body weight twice with an interval of 24 h and intramuscular injection with methyl prednisone (MPS) 20 mg/kg body weight 3 times. The dynamic changes of cbfalpha 1 gene expression in the femoral head were observed with immunohistochemistry and real-time quantitative PCR.

Results: The protein expression of cbfa 1 gene was negative in both model and treatment groups at the 4th week, it turned to weakly positive in the treatment group at the 8th and 12th week but still negative in the model group. The mRNA expression of cbfalpha 1 in the treatment group was 2.87 times that in the model group at the 12th week. There was no significant difference in cbfalpha 1 expression between the normal rabbits with or without Osteoking treatment.

Conclusion: Osteoking could promote the endogenous cbfalpha 1 expression in the FHN, the effect is better along with the prolonging of the time applied. But it showed no affection on cbfalpha 1 expression in the normal femoral head of rabbits.

Citing Articles

Network Pharmacology and Molecular Docking Elucidate the Pharmacological Mechanism of the OSTEOWONDER Capsule for Treating Osteoporosis.

Fan J, Zhou J, Qu Z, Peng H, Meng S, Peng Y Front Genet. 2022; 13:833027.

PMID: 35295951 PMC: 8918533. DOI: 10.3389/fgene.2022.833027.


Effects of Collagen- and Arginine-Fortified Osteokine Supplementation on Fracture Healing.

Karaytug K, Arzu U, Ergin O, Bilgili F, Unverengil G, Bayram S Cureus. 2021; 13(10):e19072.

PMID: 34824947 PMC: 8610439. DOI: 10.7759/cureus.19072.


Osteoking Decelerates Cartilage Degeneration in DMM-Induced Osteoarthritic Mice Model Through TGF-β/smad-dependent Manner.

Ling H, Zeng Q, Ge Q, Chen J, Yuan W, Xu R Front Pharmacol. 2021; 12:678810.

PMID: 34211396 PMC: 8239307. DOI: 10.3389/fphar.2021.678810.


Osteoking improves OP rat by enhancing HSP90‑β expression.

Sun Y, Chen R, Zhu D, Shen Z, Zhao H, Lee W Int J Mol Med. 2020; 45(5):1543-1553.

PMID: 32323753 PMC: 7138285. DOI: 10.3892/ijmm.2020.4529.


Effect of Osteoking on the osteogenic and adipogenic differentiation potential of rat bone marrow mesenchymal stem cells in vitro.

Yu C, Dai L, Ma Z, Zhao H, Yuan Y, Zhang Y BMC Complement Altern Med. 2019; 19(1):36.

PMID: 30704468 PMC: 6357478. DOI: 10.1186/s12906-019-2435-6.